US20240316060A1
University of Texas System
Treating solid tumors includes administering to a mammal in need of treatment a compound including at least one BCL-2/BCL-xl inhibitor chemically bonded on a 2D nanosheet. The compound can include Navitoclax deposited on 2D nanosheets of boron nitride to form a nanosphere via π-π stacking.